STERIS plc
steris.comWhat Do They Do?
Sells infection-prevention products and sterilization equipment to healthcare providers and medical-device and pharmaceutical manufacturers, and provides related services.
10-K for FY2026, filed May 29, 2026STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP…View ↗
Description of Business. Our Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile…View ↗
Description of Business. Our AST segment supports medical device and pharmaceutical manufacturers through a global network of contract…View ↗
Description of Business. Our Life Sciences segment provides a comprehensive offering of products and services designed to support…View ↗
How Do They Make Money?
Product customers pay for consumables and equipment when shipped or received, with integrated equipment billed after installation. Service work is billed when completed, while outsourced reprocessing and maintenance agreements are billed over their terms.
10-K for FY2026, filed May 29, 2026Product revenues consist of revenues generated from sales of consumables and capital equipment. These contracts are primarily based on a…View ↗
Within our Healthcare and Life Sciences segments, Service revenues include revenues generated from parts and labor associated with the…View ↗
We also offer preventive maintenance and separately priced extended warranty agreements to our Customers, which require us to maintain and…View ↗
Within our AST segment, Service revenues include contract sterilization and laboratory services, as well as service support for our…View ↗
-
10-K for FY2026, filed May 29, 2026
FY2026 revenue by product or service ↗
$5.9B
-
10-K for FY2026, filed May 29, 2026
$5.9B ↗
| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Product
Sold outright
10-K for FY2026, filed May 29, 2026 |
52%
FY2023: 52%
|
Product, FY2026
$3.1B Sources
|
Sold outright |
|
Service
Mix
|
48%
FY2023: 48%
|
Service, FY2026
$2.9B Sources
|
Mix |
Who Are Their Customers?
Products are sold to end users as well as dealers and distributors, which market and sell them.
10-K for FY2026, filed May 29, 2026Revenue Recognition and Associated Liabilities. Revenue is recognized when obligations under the terms of the contract are satisfied and…View ↗
Do Revenues Turn Into Profits?
Yes. It kept 13 cents of every revenue dollar as net income in FY2026 and turned 16 cents into free cash flow.
10-K for FY2026, filed May 29, 2026
$1.1BView ↗
10-K for FY2026, filed May 29, 2026
$782.3MView ↗
10-K for FY2026, filed May 29, 2026
$972.4MView ↗
How Are They Changing?
- Net income
-
Sources
10-Q for Q1 FY2027, filed Aug 7, 2026
$200.1MView ↗
- ▲ +13%
- vs $177.4M in Q1 FY2026
10-Q for Q1 FY2027, filed Aug 7, 2026
Open tableView ↗
-
Aug 5, 2026
Reiterated fiscal 2027 revenue and adjusted earnings guidance
Maintained revenue growth guidance of 7-8% and adjusted earnings per share guidance of $11.10 to $11.30.
Sources
8-K, filed Aug 5, 2026
The Company is reiterating its prior guidance for revenue and earnings for fiscal 2027. This includes as reported revenue growth of 7-8%…View ↗
Growing. Revenue grew 41% in 4 years, from $4.2B in FY2022 to $5.9B in FY2026, about 9% a year.
Dental business sale
The earlier report described dental instruments, infection-prevention products and instrument-management systems for dental practitioners and schools; the latest report excludes the Dental segment after its sale.
10-K for FY2023, filed May 26, 2023 10-K for FY2026, filed May 29, 2026
Life Sciences customer scope
The latest report describes Life Sciences as supporting medical-device manufacturing as well as biopharmaceutical manufacturing; the earlier report focused on pharmaceutical manufacturing, primarily vaccine and other biopharma customers.
10-K for FY2023, filed May 26, 2023 10-K for FY2026, filed May 29, 2026Description of Business. Our Life Sciences segment provides a comprehensive offering of products and services that support pharmaceutical…View ↗
Description of Business. Our Life Sciences segment provides a comprehensive offering of products and services designed to support…View ↗
Who Do They Compete With?
Competes with 3M, Baxter, Boston Scientific, Belimed, Ecolab, Fortive, Getinge, Karl Storz, Olympus, Ruhof, SteelCo, Stryker, Skytron, Wassenburg, BBraun, Pentax, Sterigenics, Contec, Fedegari, and Stilmas
10-K for FY2026, filed May 29, 2026Competition. We compete with a number of large companies that have significant product portfolios and global reach, as well as a number of…View ↗
Loading...
